Persisting Immune Responses Indicating Long-Term Protection after Booster Dose with Meningococcal Group B Outer Membrane Vesicle Vaccine

MenBvac is an outer membrane vesicle vaccine against systemic meningococcal disease caused by serogroup B Neisseria meningitidis. In this placebo-controlled double-blind study including 374 healthy adolescents, the safety and immunogenicity of a schedule of three primary doses 6 weeks apart followed...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Feiring, Berit, Fuglesang, Jan, Oster, Philipp, Næss, Lisbeth M., Helland, Oddveig S., Tilman, Sandrine, Rosenqvist, Einar, Bergsaker, Marianne A. R., Nøkleby, Hanne, Aaberge, Ingeborg S.
Format: Artigo
Idioma:Inglês
Publicat: American Society for Microbiology 2006
Matèries:
Vaccine Research
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC1489568/
https://ncbi.nlm.nih.gov/pubmed/16829617
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/CVI.00047-06
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars